add_icon

Sun Pharmaceutical

1,620.00
+24.70
(1.55%)
Market Cap
3,88,692.27 Cr
PE Ratio
36.50
Volume
9,28,200.00
Day High - Low
1,655.70 - 1,612.00
52W High-Low
1,851.20 - 1,548.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
3,88,692.27 Cr
EPS
45.60
PE Ratio
36.50
PB Ratio
4.92
Book Value
324.34
EBITDA
17,236.70
Dividend Yield
1.00 %
Industry
Healthcare
Return on Equity
15.15
Debt to Equity
0.04
Forecast For
Actual

Company News

View All News
Caret
positive
Sun Pharmaceutical Industries reported Q3FY26 consolidated revenue of ₹154,690.7 million (up 15.1% YoY) and net profit of ₹33,688.1 million (up 16.0% YoY). Board declared interim dividend of ₹11 per share.
neutral
Sun Pharmaceutical Industries executed a significant block trade on NSE involving 1,734,892 shares valued at ₹278.87 crores at ₹1607.40 per share, indicating substantial institutional activity.
negative
China has stopped sales of Sun Pharmaceutical's dementia drug following issues identified during a remote inspection by regulatory authorities.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,620.00
#1 3,88,692.27
#7 36.50
#1 54,729.00
#6 9.71
#1 10,980
#5 16.07
29.61
6,036.00
1,60,236.83
64.68
9,712.00
18.67
2,191
35.10
38.59
3,958.60
1,33,977.01
62.62
11,539.40
6.99
1,911
30.46
52.91
1,321.50
1,06,747.04
23.59
28,409.50
7.12
5,291
-57.18
23.33
1,219.00
1,01,741.44
18.41
33,741.20
16.73
5,725
-15.28
48.44
2,134.90
97,521.98
22.61
22,909.50
13.74
3,306
#1 72.75
53.14
883.25
88,875.62
#1 17.71
23,511.00
18.55
4,615
34.60
42.62
2,110.10
87,106.00
49.45
12,744.20
#1 20.90
2,007
-21.05
44.73
1,188.00
68,999.23
20.58
32,345.60
9.43
3,484
3.81
58.30
5,640.00
67,434.66
28.14
13,458.30
3.70
2,216
10.98
47.70
Growth Rate
Revenue Growth
9.71 %
Net Income Growth
13.80 %
Cash Flow Change
15.96 %
ROE
5.43 %
ROCE
14.46 %
EBITDA Margin (Avg.)
9.26 %

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
05 Feb 2026 DIVIDEND Dividend
11.00 /share
05 Feb 2026 1,595.00 1,595.00
10 Feb 2021 DIVIDEND Dividend
5.50 /share
09 Feb 2021 564.35 623.60
25 Aug 2021 DIVIDEND Dividend
2.00 /share
23 Aug 2021 703.80 771.35
10 Feb 2022 DIVIDEND Dividend
7.00 /share
09 Feb 2022 827.35 886.45
22 Aug 2022 DIVIDEND Dividend
3.00 /share
19 Aug 2022 903.90 901.35
08 Feb 2023 DIVIDEND Dividend
7.50 /share
08 Feb 2023 1,050.90 1,005.65
28 Jul 2023 DIVIDEND Dividend
4.00 /share
28 Jul 2023 945.00 1,134.95
09 Feb 2024 DIVIDEND Dividend
8.50 /share
09 Feb 2024 1,371.60 1,500.25
12 Jul 2024 DIVIDEND Dividend
5.00 /share
12 Jul 2024 1,541.15 1,583.25
05 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
05 Aug 2024 1,520.65 1,731.65
28 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Oct 2024 1,916.85 1,860.40
21 Jan 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
21 Jan 2025 1,806.20 1,778.25
31 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
31 Jan 2025 1,756.85 1,739.10
06 Feb 2025 DIVIDEND Dividend
10.50 /share
06 Feb 2025 1,739.10 1,753.40
22 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
22 May 2025 1,744.85 1,731.60
07 Jul 2025 DIVIDEND Dividend
5.50 /share
07 Jul 2025 1,731.60 1,676.65
31 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
31 Jul 2025 1,663.15 1,734.95
31 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
31 Jul 2025 1,731.60 1,734.95
05 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
05 Nov 2025 1,668.50 1,690.00
31 Jan 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
31 Jan 2026 1,673.55 1,595.00

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Baroda BNP Paribas Health and Wellness Fund Direct-Growth
7.17%
-55000
-1.82%
-2.08%
Canara Robeco Multi Asset Allocation Fund Direct-Growth
1.00%
-25000
-0.51%
-0.46%
PGIM India Multi Asset Allocation Fund Direct - Growth
1.70%
17850
1.70%
1.70%
Groww Multi Asset Allocation Fund Direct-Growth
0.62%
12654
0.62%
0.62%
ICICI Prudential Quality Fund Direct-Growth
6.41%
-10000
-0.47%
0.01%
Bandhan Healthcare Fund Direct - Growth
8.68%
-10000
-1.37%
8.68%
JioBlackRock Arbitrage Fund Direct - Growth
0.60%
8050
0.60%
0.60%
Franklin India Multi-Factor Fund Direct - Growth
0.18%
4997
0.18%
0.18%
ICICI Prudential Long Term Wealth Enhancement Fund Direct - Growth
2.98%
-4668
-2.17%
-1.82%
The Wealth Company Arbitrage Fund Direct-Growth
0.42%
3150
0.33%
0.35%
Bajaj Finserv Equity Savings Fund Direct-Growth
2.03%
2800
1.58%
1.59%
JioBlackRock Nifty 50 Index Fund Direct-Growth
1.53%
1992
-0.08%
-0.01%
Bajaj Finserv Nifty 50 Index Fund Direct-Growth
1.52%
1385
-0.09%
0.01%
Unifi Dynamic Asset Allocation Fund Direct - Growth
0.01%
700
0.01%
0.01%
DSP Nifty Healthcare Index Fund Direct-Growth
18.53%
631
-0.63%
0.38%
HDFC BSE India Sector Leaders Index Fund Direct-Growth
1.70%
-578
-0.14%
1.70%
Zerodha Nifty 50 Index Fund Direct - Growth
1.54%
549
-0.07%
-0.02%
Bandhan BSE India Sector Leaders Index Fund Direct-Growth
1.69%
-547
-0.15%
-0.01%
SBI Nifty100 Low Volatility 30 Index Fund Direct - Growth
3.42%
-538
-0.43%
-0.20%
Angel One Nifty 50 Index Fund Direct-Growth
1.53%
-212
-0.09%
0.02%
Nippon India Nifty India Manufacturing Index Fund Direct - Growth
4.83%
207
-0.30%
0.17%
Groww Nifty 50 Index Fund Direct-Growth
1.53%
136
-0.08%
0.02%
Zerodha BSE SENSEX Index Fund Direct-Growth
1.81%
106
-0.10%
1.81%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.86%
68
-0.06%
0.01%
HDFC Nifty Top 20 Equal Weight Index Fund Direct-Growth
4.99%
-60
-0.45%
-0.02%

Technical Indicators

RSI(14)
Neutral
29.61
ATR(14)
Less Volatile
36.40
STOCH(9,6)
Oversold
15.55
STOCH RSI(14)
Oversold
11.17
MACD(12,26)
Bearish
-8.65
ADX(14)
Strong Trend
33.01
UO(9)
Bearish
34.80
ROC(12)
Downtrend And Accelerating
-8.10
WillR(14)
Oversold
-93.61

About Sun Pharmaceutical

Sun Pharmaceutical Industries Limited is a global specialty generic pharmaceutical company based in India. It manufactures and markets a wide range of pharmaceutical formulations including generics, branded generics, complex products, over-the-counter drugs, and active pharmaceutical ingredients. The company has a diverse portfolio covering multiple therapeutic areas and dosage forms. Sun...more
Chairperson NameDilip S Shanghvi